Home
Conditions
Neoplastic Processes

Clinical trial condition

Neoplastic Processes

Explore clinical trials studying Neoplastic Processes. Study availability and eligibility vary by location and protocol.

3,267 public trials 689 recruiting studies

Refine in advanced search Browse all conditions

Neoplastic Processes trial results

Not Yet Recruiting

TLR9 Immunotherapy for Peritoneal Carcinomatosis

NCT07658196

Conditions: Abdominal Neoplasms, Adenocarcinoma, Adenocarcinoma, Mucinous, +18 more
Locations: Rhode Island and the Miriam Hospitals (Brown University Health) Providence, Rhode Island, United States

View Trial Details

Not Yet Recruiting

A Clinical Trial Comparing the Efficacy and Safety of Different Doses of BL0175 Injection in Treating Postmenopausal Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Locally Advanced or Metastatic Breast Cancer

NCT07658183

Conditions: Breast Cancer (Locally Advanced or Metastatic), Breast Diseases, Breast Neoplasms, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

MR-guided Single-fraction SBRT for Nodal Oligorecurrent Prostate Cancer (PINPOINT)

NCT07635108

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +16 more
Locations: Department of Oncology, Odense University Hospital Odense, Denmark

View Trial Details

Not Yet Recruiting

Proof of Concept for Real-time Multicentric Monitoring of MRD by PET and ctDNA in Aggressive B-Cell Lymphomas

NCT07514715

Conditions: Aggressive B-cell Lymphomas, Neoplasm, Residual, Neoplasms, +3 more
Locations: CHU D'AMIENS - HOPITAL SUD - Service Hématologie Clinique et Thérapie Cellulaire Amiens, France

CHU D'ANGERS - Service des Maladies du Sang Angers, France

CH D'AVIGNON - HOPITAL HENRI DUFFAUT - Service d'Onco-Hématologie Avignon, France

CHU JEAN MINJOZ - Service Hématologie Besançon, France

View all 30 locations

View Trial Details

Not Yet Recruiting

A Phase 2 Trial of 61Cu-NU101 PET/CT Compared Against Current Standard-of-care 18F-piflufolastat (Pylarify®) PET/CT.

NCT07635524

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +12 more
Locations: Hoag Family Cancer Institute Newport Beach, California, United States

Washington Univeristy School of Medicine St Louis, Missouri, United States

View Trial Details

Not Yet Recruiting

Registry of Minimally Invasive Cancer Treatment Using Spectral Angio-CT Image Guidance

NCT07636148

Conditions: Adenocarcinoma, Bone Cancer Metastatic, Bone Cancer Tumor, +46 more
Locations: Hospices Civils de Lyon - Hôpital Édouard Herriot Lyon, Auvergne-Rhône-Alpes, France

Assistance Publique Hopitaux de Paris - Hôpital Henri Mondor Créteil, Île-de-France Region, France

Leiden University Medical Center Leiden, South Holland, Netherlands

View Trial Details

Not Yet Recruiting

Distribution and Analysis of Metastatic Lymph Nodes in Colorectal Cancer Patients (DIAMOND)

NCT07306390

Conditions: Colon Cancer, Colonic Diseases, Colonic Neoplasms, +17 more
Locations: National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences Beijing, China

View Trial Details

Not Yet Recruiting

Exploratory Study on the Efficacy and Safety of Trastuzumab Rezetecan in the Treatment of HER2-Expressiong Advanced Solid Tumor

NCT07631884

Conditions: Advanced Malignant Solid Neoplasm, Biliary Tract Diseases, Biliary Tract Neoplasms, +56 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Liquid Biopsy in Early Colorectal Lesions

NCT07319104

Conditions: Adenocarcinoma of the Colon, Colonic Diseases, Colonic Neoplasms, +16 more
Locations: University Hospital of Amiens Amiens, France

University Hospital of Bordeaux Bordeaux, France

University Hospital of Brest Brest, France

University Hospital of Dijon Dijon, France

View Trial Details

Not Yet Recruiting

IL-15 Enhanced NK Cell Therapy for Solid Tumors

NCT07621471

Conditions: Metastatic Cancer, Neoplasm Metastasis, Neoplasms, +4 more
Locations: Xinqiao Hospital Chongqing, China

View Trial Details

Neoplastic Processes

Neoplastic Processes trial results

Related conditions